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Themechanismsbywhich themajorPolycombgroup
(PcG) complexes PRC1 and PRC2 are recruited
to target sites in vertebrate cells are not well under-
stood. Building on recent studies that determined
a reciprocal relationship between DNA methyla-
tion and Polycomb activity, we demonstrate that, in
methylation-deficient embryonic stem cells (ESCs),
CpG density combined with antagonistic effects of
H3K9me3 and H3K36me3 redirects PcG complexes
to pericentric heterochromatin and gene-rich do-
mains. Surprisingly, we find that PRC1-linked H2A
monoubiquitylation is sufficient to recruit PRC2 to
chromatin in vivo, suggesting a mechanism through
which recognition of unmethylated CpG determines
the localization of both PRC1 and PRC2 at canonical
and atypical target sites. We discuss our data in light
of emerging evidence suggesting that PcG recruit-
ment is a default state at licensed chromatin sites,
mediatedby interplaybetweenCpGhypomethylation
and counteracting H3 tail modifications.
INTRODUCTION
Polycomb group (PcG) repressor proteins play an important role
in developmental gene regulation in multicellular organisms
(Ringrose and Paro, 2004). In most cases, they are assigned as
components of one of two major multisubunit complexes, Poly-
comb repressive complex 1 (PRC1) and PRC2, both of which
have intrinsic histone-modifying activities (monoubiquitylation
of histone H2A lysine 119 [H2AK119u1] and methylation of his-
tone H3 lysine 27 [H3K27me1/2/3], respectively; reviewed in
Simon and Kingston, 2013). Vertebrates possess several variant1456 Cell Reports 7, 1456–1470, June 12, 2014 ª2014 The AuthorsPRC1 complexes, as defined by the presence of the subunit
PCGF1-6 (Gao et al., 2012). The histone-modifying activities of
PRC1 and PRC2 are of central importance for PcG function (En-
doh et al., 2012; Pengelly et al., 2013), although several studies
have revealed that PRC1 alsomediates repression through alter-
native mechanisms (Eskeland et al., 2010; Francis et al., 2004;
Isono et al., 2013). Canonical PRC1 and PRC2 function in a hier-
archical manner, with PRC1 recruitment occurring via binding of
the chromodomain of the Cbx Polycomb subunit to PRC2-medi-
ated H3K27me3 (Cao et al., 2002; Wang et al., 2004). More
recent studies have demonstrated that variant PRC1 complexes
are recruited through PRC2-independent mechanisms (Schoeft-
ner et al., 2006; Tavares et al., 2012).
In vertebrates, cytosine residues at CpG dinucleotides are
extensively methylated, with the exception of CpG islands
(CGIs), which are found at the promoter region of more than
50% of genes (reviewed in Illingworth and Bird, 2009). DNA
methylation is required for normal development, but not for the
maintenance of embryonic stem cells (ESCs) in vitro (reviewed
in Bestor, 2000). DNA methylation patterns are erased in early
embryos and developing germ cells, and are then reestablished
by the de novo DNA methyltransferases Dnmt3a and Dnmt3b,
and the accessory protein Dnmt3L (reviewed in Reik et al.,
2001). Propagation of DNA methylation patterns through DNA
replication is dependent on the maintenance DNA methyltrans-
ferase, Dnmt1, and the accessory protein Uhrf1 (Bestor, 2000;
Sharif et al., 2007).
InDrosophila, PcG recruitment at Hox loci, as well as other tar-
gets, is mediated by transcription factor binding at sequences
designated as Polycomb response elements (Kassis and Brown,
2013;Mohd-Sarip et al., 2005). Inmammalian cells, PcGproteins
are recruited to target gene promoters and also to atypical sites,
specifically the inactive X chromosome (de Napoles et al.,
2004; Plath et al., 2003; Silva et al., 2003), and paternal pericen-
tric heterochromatin (PCH) domains in early mouse embryos
(Puschendorf et al., 2008; Santos et al., 2005). There is evidence
supporting a role for sequence-specific factors in PcG recruit-
ment in mammals (Woo et al., 2010, 2013), and also suggesting
a role for noncoding RNA (reviewed in Brockdorff, 2013). Addi-
tionally, several studies have demonstrated a link between
unmethylated CpG residues and PcG recruitment/binding. Spe-
cifically, PcG occupancy correlates closely with CpG density in
CGIs at target gene promoters (Lynch et al., 2012; Mendenhall
et al., 2010). Moreover, depletion of DNA methylation has been
correlated with changes in patterns of PRC2 localization (Brink-
man et al., 2012; Reddington et al., 2013). Linked to these obser-
vations, recent studies have demonstrated that recruitment of
the variant PRC1 complex PCGF1-PRC1 is dependent on bind-
ing of the KDM2B subunit to unmethylated CpG residues via a
CXXC-zinc finger domain (Farcas et al., 2012; He et al., 2013;
Wu et al., 2013). Interestingly, a chromatin immunoprecipitation
sequencing (ChIP-seq) analysis of KDM2B demonstrated occu-
pancy, albeit at a reduced level, at all CGIs, including those asso-
ciated with active genes (Farcas et al., 2012). Based on these
findings, we have proposed that PcG complexes bind CGIs as
a default, with patterns of occupancy being defined on the one
hand through reinforcement by positive-feedback mechanisms,
and on the other hand by antagonizing chromatin modifications
(e.g., H3K4me3 mediated by Trithorax group factors) at CGIs of
active genes (Klose et al., 2013).
Here, we show that both PRC1 and PRC2 activities are redir-
ected to noncanonical targets, PCH domains, and other CpG-
rich sites, notably gene exons, in embryonic stem cells (ESCs)
in which DNA methylation is depleted, and that this is inhibited
by the presence of preexisting histone tail modifications, notably
H3K9me3 and H3K36me3. Thus, PcG occupancy patterns are a
combinatorial readout of unmethylated CpG density and antag-
onism by specific chromatin modifications. We find that teth-
ering PRC1 proteins to PCH in wild-type (WT) cells is sufficient
to establish both H2AK119u1 and PRC2-mediated H3K27me3.
Moreover, we show that the observed PRC2 recruitment is
directly linked to deposition of H2AK119u1. These observations
define a mechanism that potentially explains the recruitment of
both PRC1 and PRC2 to unmethylated CpG sites in the verte-
brate genome.
RESULTS
Loss of DNA Methylation Recruits PcG Complexes to
PCH
PCH in mouse comprises large blocks of major and minor satel-
lite repeat sequences (Figure S1A) in which the chromatin is
modified with H3K9me3, H4K20me3, and associated binding
proteins, notably heterochromatin protein 1 (Probst and Al-
mouzni, 2011). Atypical localization of PcG complexes and asso-
ciated modifications occur on paternal PCH in early embryos
(Santos et al., 2005) and have been linked to absence of H3K9
methylation (Puschendorf et al., 2008). Taking into consideration
emerging evidence for an antagonistic effect of DNAmethylation
on PcG activity (Brinkman et al., 2012; Hagarman et al., 2013;
Lynch et al., 2012; Reddington et al., 2013), we speculated
that programmed DNA demethylation of the paternal genome
in fertilized zygotes (Mayer et al., 2000; Oswald et al., 2000)
may also play a role. To test this idea, we performed an immuno-Cfluorescence (IF) analysis to detect PRC1-mediated H2AK119u1
and PRC2-mediated H3K27me3 in Dnmt1/Dnmt3a/Dnmt3b tri-
ple knockout (Dnmt TKO) embryonic stem cells (ESCs), in which
DNA methylation is depleted to 0.1%–0.4% of the levels seen in
WT cells (Tsumura et al., 2006). We observed both H2AK119u1
and H3K27me3 foci colocalizing with DAPI-dense PCH domains
in a large proportion of Dnmt TKO, but notWT, ESCs (Figures 1A,
1B, and S1B), demonstrating that CpG hypomethylation is suffi-
cient to recruit PcG complexes. An unbiased quantitative anal-
ysis revealed that Dnmt TKO ESCs have a significant enrichment
of H3K27me3 and H2AK119u1 in DAPI-dense domains relative
to the whole nucleus (Figure 1C). A western blot analysis indi-
cated that the global levels of PcG proteins and associated
histone modifications were similar in WT and Dnmt TKO ESCs
(Figure S1C).
We determined the kinetics of H3K27me3 and H2AK119u1
deposition at PCH domains using ESCs with a tamoxifen-induc-
ible knockout allele for Uhrf1, a factor required for the mainte-
nance of DNA methylation (Sharif et al., 2007). Similarly to
Dnmt TKO ESCs, both H3K27me3 and H2AK119u1 localized
to PCH in constitutive Uhrf1/ ESCs, but not in Uhrf1flox/flox
controls (Figures S2A and S2B). We therefore treated
Uhrf1flox/flox ESCs with tamoxifen and assayed depletion of
DNAmethylation at major satellite repeats by Southern blot (Fig-
ure 2A), and acquisition of H3K27me3 and H2AK119u1 at PCH
by IF (Figure 2B) over time. The results demonstrate a close cor-
relation between the rate of depletion of DNA methylation and
the deposition of H3K27me3/H2AK119u1 at PCH (Figure 2C).
We obtained similar findings using a tamoxifen-inducible
knockout ESC model for the maintenance DNA methyltransfer-
ase Dnmt1 (Figures S2C and S2D). These findings substantiate
that DNA hypomethylation results in H3K27me3/H2AK119u1
deposition at PCH in ESCs, and moreover suggest a direct
causative link.
We also analyzed Dnmt1/ mouse embryonic fibroblasts
(MEFs), which were previously shown to be extensively depleted
of DNA methylation (Lande-Diner et al., 2007), to determine
whether localization of H2AK119u1 and H3K27me3 to PCH
occurs in a differentiated cell type. As illustrated in Fig-
ure 2D, H2AK119u1 was indeed found at PCH, but, interestingly,
H3K27me3 foci were not detectable (Figure 2D). This observa-
tion indicates that PCH domains in differentiated cells have
distinct characteristics (also see below).
H3K9me3 at PCH Antagonizes PRC2, but Not PRC1,
Activity
Although both H3K27me3 and H2AK119u1 were seen at PCH in
DNAmethylation-depleted ESCs, we noted that the frequency of
H3K27me3 foci was lower than the H2AK119u1 foci (Figures S3A
and S3B), indicating that PCH may be somewhat refractory
to PRC2 activity. Previous studies noted the appearance of
H3K27me3 at PCH when H3K9me3, a histone tail modification
that is normally concentrated at these sites, is depleted (Peters
et al., 2003; Puschendorf et al., 2008). We therefore investigated
the interplay between H3K9me3 and both H3K27me3 and
H2AK119u1 in methylation-deficient Dnmt TKO compared with
WT ESCs. As illustrated in Figures 3A and S3C, H2AK119u1
and HP1a (which binds to H3K9me3) show extensive overlapell Reports 7, 1456–1470, June 12, 2014 ª2014 The Authors 1457
Figure 1. PcG Complexes Localize to PCH
in Response to Loss of DNA Methylation
(A) IF of Dnmt TKO and WT cells stained for
H2AK119u1 (PRC1) or H3K27me3 (PRC2), and
DNA stained with DAPI. Yellow lines show total
nuclear area (left) and PCH domains (right) based
on DAPI staining defined by the ImageJ threshold
algorithm Triangle.
(B) Graph showing the percentage of cells with
PCH foci positive for H2AK119u1 or H3K27me3 in
WT or Dnmt TKO cells. Bars show average (n > 200
DAPI foci) ± SD (n = 3).
(C) Box and whisker plot showing quantification of
fluorescence intensities at PCH domains. The total
nuclear area and PCH domains were defined as
shown by the yellow lines in (A). Fluorescence in-
tensity (H2AK119u1 or H3K27me3 staining) was
calculated within the defined PCH domains in
either WT or Dnmt TKO cells and is expressed
relative to the fluorescence intensity within the
total nuclear area of the cell (n = 20, p values
Student’s t test, unpaired).
Scale bars represent 5 mm. See also Figure S1.with one another, encompassing the entire PCH domains. In
contrast, H3K27me3 and H3K9me3 appear nonoverlapping,
although both lie within DAPI-stained PCH domains (Figure 3B).
We verified these observations using superresolution 3D
structured illumination microscopy (3D-SIM), a technique that
offers significantly enhanced spatial resolution compared with
conventional fluorescence microscopy (Schermelleh et al.,
2010). Representative examples shown in Figure 3C illustrate
that in Dnmt TKO ESCs, H3K27me3 and H3K9me3 are enriched
in distinct subdomains within PCH clusters.
The mutually exclusive deposition of H3K9me3 and
H3K27me3 at PCH foci in ESCs suggests that these histone
modifications may antagonize one another. Consistent with
this, H3K27me3 foci in Suv3-9h1/h2 double knockout (DKO)
ESCs, in which H3K9me3 at PCH is entirely depleted (Peters
et al., 2001), were more extensive than in DNA methylation-
depleted Dnmt TKO ESCs (Figure S3D). Moreover, in contrast
to Dnmt TKO ESCs, H3K27me3 in Suv3-9h1/h2 DKO ESCs1458 Cell Reports 7, 1456–1470, June 12, 2014 ª2014 The Authorswas detected in the majority of PCH
domains, again similar to what was
observed for H2AK119u1 (Figure S3E).
To further investigate the apparent antag-
onism of H3K27me3 by H3K9me3, we
used RNAi to deplete Suv3-9h1/h2 (and
hence H3K9me3) in DNA methylation-
depleted (Uhrf1/) ESCs (Figure S3F),
and then analyzed H3K27me3 at PCH.
The extent of H3K27me3 domains
was clearly increased in Suv3-9h1/h2
knockdown cells (Figure 3D), as was
their frequency (Figure 3E). Moreover,
we observed extensive H3K27me3
and H2AK119u1 domains in WT ESCs
following Suv3-9h1/h2 depletion (Fig-
ure S3G). Taken together, these resultsindicate that H3K9me3 and H3K27me3 modifications are mutu-
ally antagonistic at PCH domains in ESCs.
Unmethylated CpG Titrates PcG Complexes
We went on to investigate PcG localization genome-wide
following depletion of DNA methylation by performing a ChIP-
seq analysis of H3K27me3, Suz12 (a core subunit of PRC2),
and Ring1B (the catalytic subunit of PRC1) in Dnmt TKO and
WT ESCs. Determination of the fold change in Dnmt1 TKO
compared with WT ESCs at repetitive sequences, which collec-
tively comprise approximately 45% of the genome, demon-
strated enhanced levels of H3K27me3, Suz12, and Ring1B at
major satellite sequences and, to a lesser extent, at minor satel-
lite sequences (Table S1; Figure 4A), consistent with the IF data.
Other common repeat sequence classes showed minimal fold
changes, with a moderate reduction of H3K27me3 at L1 repeats
and a slight increase of H3K27me3, Suz12, and Ring1B at SINE
repeats (Figure 4A).
Figure 2. PcG Complexes Are Dynamically
Acquired at PCH upon Loss of DNA
Methylation
(A) Southern blot showing loss of DNAmethylation
over time upon loss of Uhrf1. Genomic DNA from
WT, Dnmt TKO, or tamoxifen-induced deletion of
Uhrf1 in conditional knockout cells (0–120 hr) was
digested with the methylation-sensitive enzyme
HpyCH41V and the blot was probed for major
satellite repeats.
(B) IF of conditional knockout Uhrf1/ cells (72 hr,
tamoxifen treatment) stained for H2AK119u1 or
H3K27me3. Arrowheads indicate an example of
staining within PCH.
(C) Graph showing the percentage of cells with
H3K27me3 or H2AK119u1 foci during the Uhrf1/
deletion time course. Bars show average (n > 200
cells) ± SD (n = 3).
(D) IF of Dnmt1/ (and control) MEF cells stained
for H2AK119u1 and H3K27me3. Arrowheads
indicate a single PCH domain.
Scale bars represent 5 mm. See also Figure S2.Recent genome-wide studies have reported aberrant
H3K27me3 localization at unique sequences in DNA methyl-
ation-deficient ESCs. Specifically, decreased levels occurred
at CGIs of canonical PcG target loci (Brinkman et al., 2012; Red-
dington et al., 2013) and increased levels occurred at sites where
DNA methylation levels were relatively high, notably in gene-rich
chromosomal domains (Brinkman et al., 2012; Hagarman et al.,
2013; Lynch et al., 2012; Reddington et al., 2013). We hypothe-
sized that these opposite effects could be attributable to a titra-
tion of PcG complexes to newly acquired unmethylated CpG
sites, including major satellite sequences, leading to a reduction
in levels at canonical target sites. To investigate this, we first
quantified PcG localization at canonical target loci by deter-
mining the fold change in Dnmt TKO relative to WT at known
CGIs, as defined by biotin CXXC affinity purification sequencing
(BioCAP-seq) experiments (Long et al., 2013b). Consistent
with previous studies (Brinkman et al., 2010; Reddington et al.,Cell Reports 7, 1456–1472013), we observed that Dnmt TKO
ESCs had reduced levels of H3K27me3,
Ring1B, and Suz12 at WT PcG sites (Fig-
ure 4B). An example of a single PcG
target locus, the Gata6 gene, is shown
in Figure 4C, and further validation
using ChIP-qPCR for H3K27me3 and
H2AK119u1 at selected loci is shown in
Figure 4D. We next determined the rela-
tionship between PcG occupancy and
CpG density at non-CGI sequences by
performing a whole-genome sliding-win-
dow analysis. We excluded embryonic,
somatic, and germ cell CGIs as defined
by BioCAP-seq analyis of ESCs, liver,
and testis (Long et al., 2013b). Figure 4E
shows a positive fold change (new
sites) for non-BioCAP-seq regions binned
according to CpG content, and reveals astriking correlation between the fold increase for H3K27me3 and
the overall CpG content. Such a fold increase, albeit less pro-
nounced, was also seen for Suz12 and Ring1B. We validated
increased H3K27me3 at selected new sites by conventional
ChIP and also demonstrated a similar increase in H2AK119u1
(Figure 4D). Taken together, these observations support the
idea that unmethylated CpG sites are a primary determinant of
PcG occupancy in Dnmt TKO ESCs.
A previous analysis of methylation-deficient ESCs docu-
mented a gain of H3K27me3 over large gene-rich chromosomal
domains (Brinkman et al., 2012). We considered that this could
be linked to the higher CpG density that has been reported to
occur in gene exons (Lander et al., 2001). Importantly, we deter-
mined that the high CpG content of exons is evident even when
exon 1, which frequently overlaps with promoter-associated
CGIs, is excluded (4.9% CpG compared with 1.8% in introns).
We therefore analyzed the fold change in H3K27me3, Suz12,0, June 12, 2014 ª2014 The Authors 1459
Figure 3. H3K9me3 Antagonizes PRC2, but Not PRC1
(A) IF of Dnmt TKO cells costained for H2AK119u1 and HP1a. The graph shows a profile plot of fluorescence intensity (arbitrary units [A.U.]) across a single PCH
domain (2 mM) defined by DAPI and marked on the merge image as a yellow bar.
(B) As in (A), but costained for H3K27me3 and H3K9me3.
(C) Superresolution 3D-SIM images of Dnmt TKO and WT cells stained with H3K27me3 (green), H3K9me3 (red), and DAPI (blue). Upper panels show a single xy
plane and bottom panels show an orthogonal xz plane. Arrowheads indicate the cutting plane. Middle panels show a single PCH region (delineated with a white
line), and merges show overlap of each color. Arrowheads mark H3K27me3 staining within PCH in Dnmt TKO cells.
(legend continued on next page)
1460 Cell Reports 7, 1456–1470, June 12, 2014 ª2014 The Authors
andRing1B in Dnmt TKO relative toWT ESCs for gene exons (not
exon 1) and for introns. As shown in Figure S4A, exons (excluding
exon 1), but not introns, show clearly increased H3K27me3 and,
to a lesser extent, Ring1B and Suz12 levels, correlating with their
relative CpG content.
In vitro analysis has shown that PRC2-mediated H3K27me3
is inhibited when H3K36me2/3 is present on the same H3
tail (Schmitges et al., 2011; Yuan et al., 2011). Given that
H3K36me3 is normally associated with the gene bodies of
actively transcribed genes, we obtained H3K36me3 profiles for
Dnmt TKO ESCs, defined H3K36me3-positive and -negative
exons (not exon 1) (Figures S4B–S4D), and then determined
PcG acquisition for these two exon categories in Dnmt TKO rela-
tive to WT. Consistent with the inhibitory effect of H3K36me3
on PRC2 activity, we observed little or no fold increase of
H3K27me3 or the PRC2 subunit Suz12 at H3K36me3-positive
exons, despite their high CpG content (4.7%) (Figure 4F). A
similar effect was observed for Ring1B. We conclude that PcG
redistribution at unique sequences in Dnmt TKO ESCs is a
combinatorial readout of the density of unmethylated CpG den-
sity coupled to antagonism of PRC2 by H3K36me3 in the gene
bodies of active genes.
PRC1 and PRC2 Activity Is Not Dependent on DNA
Hypomethylation
Previous studies provided evidence for a direct effect of DNA
methylation on binding/recruitment of PRC2 (Bartke et al.,
2010; Wu et al., 2010). To investigate this, we assayed the activ-
ity of PRC2 (comprising the core subunits Ezh2, Eed, Suz12, and
RbAp48) in vitro using chromatin templates reconstituted on a
601 nucleosome positioning sequence with a CpG density of
8.7%, which is similar to that of a CGI (Figures 5A and S5A).
To verify the assay conditions, we confirmed that recombinant
PRC2 was inhibited using an unmethylated DNA template and
nucleosomes reconstituted with H3Kc36me3, relative to unmod-
ified H3, as previously shown (Schmitges et al., 2011; Figure 5B,
left panels). We then determined activity using either unmethy-
lated or methylated DNA templates. As shown in Figure 5B
(right panels), there was no discernible inhibition of PRC2 using
the methylated template. Similarly, H2A ubiquitylation activity
in vitro, assayed using a recombinant PRC1 complex comprising
Ring1B, Mel-18, and Rybp (Tavares et al., 2012), was unaffected
by DNA methylation (Figure 5C). These experiments argue
against a direct effect of DNA methylation on the activity of the
tested PRC1 and PRC2 complexes.
We went on to determine whether DNAmethylation directly in-
hibits PcG activity in vivo. To that end, wemade use of theMBD1
methyl binding domain (MBD), which binds to densely methyl-
ated DNA, including at PCH domains (Hendrich and Bird,
1998; Ng et al., 2000), to tether PcG complexes in WT ESCs
with normal levels of DNAmethylation (Figure 5D). In initial exper-
iments, we constructed MBD fusion proteins for Ezh2 and(D) Stable knockdown of Suv3-9h1/h2 or a scrambled control in Uhrf1/ cells cos
domain, marked on the merge image as a yellow bar.
(E) Graph showing the percentage of DAPI foci staining for H3K27me3 in Uhrf1/
Bars show average (n > 200 DAPI foci) ± SD (n = 3).
Scale bars represent 5 mm (unless otherwise stated). See also Figure S3 and Tab
CRing1B, the catalytic subunits of PRC2 and PRC1, respectively
(Figure 5A). Expression of full-length fusion protein was validated
by western blot analysis (Figure S5B). IF with anti-FLAG demon-
strated localization of fusion proteins to PCH domains following
transient transfection (Figures 5E–5G). The MBD-Ezh2 fusion
protein was active, as indicated by the establishment of
H3K27me3 at PCH domains (Figure 5E). Similarly, recruitment
of an MBD-Ring1B fusion protein to methylated PCH domains
in WT ESCs led to H2AK119u1 deposition (Figure 5F). These
results argue that CpG methylation does not directly inhibit the
activity of either PRC2 or PRC1 complexes.
Establishment of H3K27me3 at PCH by tethering MBD-Ezh2
did not lead to recruitment of H2AK119u1 (Figure 5G). This
was unexpected given the prevailing view that H3K27me3 re-
cruits canonical PRC1 complexes via interaction with the chro-
modomain of the CBX subunit. To test whether the absence
of H2AK119u1 is attributable to inhibition of PRC1 activity or
recruitment, we transfected either MBD-Ring1B or MBD-Ezh2
into cells stably expressing the canonical PRC1 subunit Cbx7
fused to GFP (GFP-Cbx7). Cbx7-GFP was recruited to PCH
when we tethered MBD-Ring1B (because both subunits are in
the same complex), but not in response to tethering of MBD-
Ezh2 (Figure S5C). We conclude that the chromatin features of
PCH in ESCs block binding of Cbx PcG proteins and hence ca-
nonical PRC1 to H3K27me3. This contrasts with CGI PcG target
sites where H3K27me3 does recruit Cbx-PRC1 (Tavares et al.,
2012). Interestingly, MBD-Ezh2 tethering to PCH in MEF cells
did not result in H3K27me3 deposition (Figure 5H). This is
consistent with the absence of PRC2-mediated H3K27me3 at
PCH domains in Dnmt1/ MEFs (Figure 2D) and indicates
that PCH in differentiated MEFs is entirely refractory to PRC2
activity.
KDM2B Recruitment Is Sufficient for H2AK119u1 and
H3K27me3 Deposition at PCH
In light of our observations indicating that DNAmethylation does
not antagonize PcG activity directly, we went on to investigate
possible indirect mechanisms. Recent studies have revealed
that the zinc finger CXXC (zf-CXXC) domain recruits specific
chromatin-modifying factors to CGIs via binding to unmethy-
lated CpG (Long et al., 2013a). One of these factors, KDM2B,
is an H3K36me1/2 demethylase that is also a subunit of a variant
PRC1 complex, PCGF1-PRC1 (Farcas et al., 2012; He et al.,
2013; Wu et al., 2013). We therefore exploited the MBD fusion
tethering assay described above to test whether recruitment of
KDM2B could account for H2AK119u1 deposition at PCH. We
mutated a critical residue in the zf-CXXC domain of KDM2B (Fig-
ure 6A) such that the fusion protein could bind tomethylated, but
not unmethylated, CpG. We found that MBD-KDM2B recruit-
ment was sufficient for H2AK119u1 deposition at PCH (Figures
6B, left, and 6E). Interestingly, we also observed H3K27me3
deposition (Figure 6B, right, and 6E), albeit in a smallertained for H3K27me3 and H3K9me3. Profile plots as in (A) across a single PCH
cells with either scrambled control or stable knockdown (KD) of Suv3-9h1/h2.
le S2.
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Figure 4. Loss of DNA Methylation Redis-
tributes PcG Complexes Away from Canon-
ical Sites to New Sites Depending on CpG
Content and H3K36me3 Occupancy
(A) Graph showing at the indicated repeat regions
the fold change of reads, normalized to total reads,
from ChIP-seq analysis of Input, H3K27me3,
Ring1B, and Suz12 in Dnmt TKO relative to WT
cells. The %CpG of each repeat class is shown.
Two bars represent biological repeats.
(B) As in (A), but with fold change at BioCAP-seq
positive regions (WT unmethylated CpG regions).
(C) Screen shot of one biological repeat of ChIP-
seq of H3K27me3, Ring1B, Suz12, and Input in
WT and Dnmt TKO cells.
(D) ChIP-qPCR of H3K27me3 or H2AK119u1 at
canonical targets or new sites in WT and Dnmt
TKO cells. Bars show average ± SD (n = 3).
(E) Graphs showing a positive fold change in
Dnmt TKO versus WT cells using a sliding-window
analysis of H3K27me3, Ring1B, and Suz12 ChIP-
seq of only BioCAP-seq-negative regions, binned
according to CpG content.
(F) As in (A), but with fold change at H3K36me3-
positive or -negative exons, or introns.
See also Figure S4 and Tables S1, S2, and S3.proportion of cells. This was unexpected given that PRC2 is not
known to interact with KDM2B /PCGF1-PRC1 (Farcas et al.,
2012; He et al., 2013; Wu et al., 2013).
KDM2B isahistonedemethylasewithspecificity forH3K36me1/
2, a modification that, similarly to H3K4me3 and H3K36me3, in-
hibits PRC2 in cis on the same histone H3 tail in vitro (Schmitges
etal., 2011).To testwhether theH3K36me1/2demethylaseactivity
of KDM2Bcould account for H3K27me3deposition,we tethereda1462 Cell Reports 7, 1456–1470, June 12, 2014 ª2014 The Authorscatalytically inactive MBD-KDM2B fusion
with a mutation in the JmjC domain
(Figure 6A). As shown in Figures 6C and
6E, deposition of both H2AK119u1 and
H3K27me3 was unaffected, indicating
that the demethylase activity of KDM2B
is not required for H3K27me3 deposition.
Moreover, when we used the MBD
domain to tether KDM2A, a closely related
H3K36me1/2 demethylase that does not
interact with PRC1 components (Black-
ledge et al., 2010; Farcas et al., 2012), we
failed to observe either H2AK119u1 or
H3K27me3 (Figures S6A–S6C).
To verify that tethering KDM2B is suffi-
cient for deposition of both H2AK119u1
and H3K27me3, we established a stable
ESC line with a doxycycline-inducible
MBD-KDM2B transgene (Figure S6D).
Consistent with results obtained using
transient transfection, we detected
deposition of both H2AK119u1 and
H3K27me3 at PCH domains (Figures 6F
and S6E). To test whether associationof KDM2B with other PRC1 subunits is required for
H3K27me3 deposition, we established a stable doxycycline-
inducible ESC line expressing MBD-Ring1B (Figure S6F). As
illustrated in Figures 6D and 6F, MBD-Ring1B localized to
PCH domains following tamoxifen induction. This resulted in
deposition of H2AK119u1, as expected, but also, importantly,
to deposition of H3K27me3. Thus, recruitment of either
KDM2B or Ring1B to PCH domains in WT ESCs is sufficient
to establish both H2AK119u1 and H3K27me3 histone
modifications.
H2AK119u1 Recruits PRC2
Recruitment of PRC2 activity by KDM2B/Ring1B could be due
to a protein-protein interaction or, alternatively, to a PRC1-
linked modification of underlying chromatin. We were particu-
larly interested in determining whether H2AK119u1 might have
a direct role in recruiting PRC2. To test this, we fused the
RING finger domains of Ring1B and PCGF4 to generate a min-
imal catalytic complex that lacks the C-terminal domains
required for interaction with other PRC1 subunits (Bezsonova
et al., 2009). Previous studies have shown that in vitro, the
two RING finger domains dimerize to form an E3 ligase with
high specificity for H2AK118/9 on nucleosomal substrates
(Bentley et al., 2011; Buchwald et al., 2006; Li et al., 2006).
Based on the crystal structure of this complex, which shows
that the C terminus of the Ring1B ring finger and the
N terminus of PCGF4 ring finger are in close proximity to each
other (Bentley et al., 2011), we inserted a short linker to allow
expression of the E3 ligase as a single polypeptide (Figure 7A),
thereby minimizing the possibility of interactions with endoge-
nous Ring1(A/B) or Pcgf1-6 proteins in cells. Ring1B/Pcgf4 cat-
alytic domain (RPCD) protein was tagged with glutathione S-
transferase (GST), expressed, and purified from E. coli. We
then verified RPCD activity and specificity by assaying H2A
ubiquitylation on reconstituted nucleosomal templates in vitro
(Figure S7A). We also designed a catalytically inactive fusion
protein by mutating a critical residue in the E2 binding surface
of Ring1B (I53A) and in the zinc finger of Pcgf4 (C51G) (Figures
7A and S7A).
To test RPCD in vivo, we expressed an MBD-RPCD fusion
protein with a FLAG C-terminal tag in ESCs. We verified that
the fusion protein did not interact with endogenous PRC1 or
PRC2 proteins by conducting a coimmunoprecipitation (coIP)
analysis of Rybp, which is associated in complexes with all of
Pcgf1-6 (Gao et al., 2012; Tavares et al., 2012), endogenous
Ring1B, and the core PRC2 subunit Suz12. As shown in Fig-
ure S7B, Rybp coimmunoprecipitated with endogenous
and MBD-tagged Ring1B, but not with RPCD. Similarly, neither
endogenous Ring1B nor Suz12 coimmunoprecipitated with
RPCD.
We went on to establish stable doxycycline-inducible ESCs
expressing either active or mutant MBD-RPCD. The expression
levels following addition of doxycycline were estimated to be
similar to those in the stable MBD-Ring1B cell line described
above, as determined by anti-FLAG western blot analysis (Fig-
ure S7C). When MBD-RPCD was recruited to PCH domains,
we observed efficient deposition of H2AK119u1 and, impor-
tantly, H3K27me3 (Figures 7B and 7C). Neither modification
could be detected following recruitment of mutant RPCD (Fig-
ures 7B and 7C). Recruitment of MBD-RPCD had no discernible
effect on the levels of either H3K9me3 or DNA methylation at
PCH (Figures S7D and S7E). These results thus demonstrate
that H2AK119u1 deposition is sufficient to recruit PRC2. We
note that this mechanism could potentially explain the localiza-
tion of both PRC1 and PRC2 activities at PCH and other CpG-
dense sites in DNA methylation-deficient ESCs.CDISCUSSION
A Role for DNA Hypomethylation in Atypical Localization
of PcG Proteins to PCH Domains
Localization of PcG complexes to paternal PCH in early mouse
embryos has been attributed to the absence of H3K9me3
(Puschendorf et al., 2008). We hypothesized that DNA hypo-
methylation may also play a role, and consistent with this, we
observed a rapid recruitment of PRC1 and PRC2 activities
to PCH in ESCs following depletion of DNA methylation, despite
the continued presence of H3K9me3. Our results do, however,
support a role for H3K9me3 in antagonizing PRC2 activity at
PCH. Specifically, we observed mutually exclusive staining for
H3K9me3 and H3K27me3, contrasting with the broader staining
pattern for H2AK119u1. Moreover, depletion of H3K9me3 by
knockdown of Suv39h1/h2 resulted in increased H3K27me3 at
PCH. H3K9me3 does not inhibit PRC2 activity in vitro (Schmitges
et al., 2011), arguing against direct inhibition of PRC2 activity
by H3K9me3 in cis on the same histone tail. With this in mind,
we favor the idea that antagonism of PRC2 by H3K9me3
at PCH is an indirect effect, mediated by H3K9me3-binding
proteins such as HP1.
Unlike the case with H3K27me3, H2AK119u1 deposition
at PCH in Dnmt TKO ESCs is not antagonized by H3K9me3.
This raises the question of how H2AK119u1 deposition at
PCH occurs in Suv39H1/2 DKO ESCs. Our results suggest
that H2AK119u1 deposition is unlikely to be attributable to
H3K27me3-mediated recruitment of canonical PRC1 com-
plexes, given that this does not occur when H3K27me3 is
directed to PCH in WT ESCs (Figure 5G). A possible explanation
comes from the observation that H3K9me3 is required for effi-
cient DNA methylation at PCH (Lehnertz et al., 2003). Thus,
DNA hypomethylation in Suv39H1/2 DKO ESCs could recruit
PRC1 activity, similar to what is observed in Dnmt TKO ESCs
(see below). It should be noted that the absence of canonical
PRC1 recruitment at H3K27-methylated PCH is unexpected.
We interpret this to indicate that Polycomb Cbx proteins
are unable to bind to H3K27me3 due to a specific characteristic
or modification at PCH.
We also show that PcG activity/recruitment at PCH is depen-
dent on developmental context. Specifically, in Dnmt1/ MEF
cells, we observed accumulation of H2AK119u1, but never
H3K27me3. This was the case even following depletion of
H3K9me3 (data not shown). Related to this, in contrast to
ESCs, tethering Ezh2 to PCH in WT MEFs did not lead to
H3K27me3 deposition. These observations demonstrate that
PCH in somatic cells is highly refractory to PRC2 activity. Inhibi-
tion of PRC2 may be linked to the fact that PCH chromatin is
considerably less dynamic in somatic cells relative to ESCs
(Meshorer et al., 2006). Thus, we propose interplay of mutually
exclusive chromatin repressionmachineries, with the equilibrium
state being defined in part by chromatin dynamics.
Unmethylated CpG Dictates PcG Occupancy
Our study extends recent reports of a changed distribution of
H3K27me3 in DNA methylation-deficient ESCs (Brinkman et al.,
2012)andsomaticcell lines (Reddingtonetal., 2013).Specifically,
we mapped H3K27me3, Suz12, and Ring1B redistribution inell Reports 7, 1456–1470, June 12, 2014 ª2014 The Authors 1463
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Dnmt TKO ESCs, and also performed an extended analysis to
include common repeat elements. These analyses demonstrate
that both PRC1 and PRC2 are redistributed away from canonical
PcG targets. Moreover, by subtracting ESC PcG target se-
quences from our analysis, we were able to show that there is a
linear relationship between the gain of PcG complexes and the
density of unmethylated CpG, notably at exon sequences that
are known to have a relatively high CpG density. By taking into
consideration the levels of H3K36me3, which was previously
shown to inhibit PRC2 activity, we further refined the principles
for PcG redistribution following depletion of CpG methylation.
Together, our observations indicate that PcG redistribution at
unique sequences in Dnmt TKO ESCs is a combinatorial readout
of the density of unmethylatedCpGand the presence/absence of
H3K36me3. We note that modified patterns of DNA methylation
could also explain the observed changes in patterns of PcG
occupancy in ESCs grown in 2i conditions (Ficz et al., 2013; Hab-
ibi et al., 2013; Marks et al., 2012), in Dnmt3a-deficient neural
stem cells (Wu et al., 2010), and in cancer cell lines (Varley
et al., 2013). In the context of the default model for PcG recruit-
ment (Klose et al., 2013), we suggest that other histone tail mod-
ifications, notably H3K4me3, which antagonizes PRC2 activity,
must also be taken into account in order to fully explain PcG
occupancy patterns in different cell types.
Although we detected gain of both H3K27me3 and
H2AK119u1 at new sites in Dnmt TKO ESCs, this was less
obvious when we analyzed Suz12 and Ring1B. A possible expla-
nation for this is that at new sites, PcG complexes interact with
chromatin with relatively fast dynamics and as such evade
capture by formaldehyde crosslinking (Schmiedeberg et al.,
2009). Fast dynamics at the relatively short CpG-rich exonic sites
could be linked to an absence of positive-feedback mechanisms
that stabilize PcG complexes at CGI targets. The enhancement
of PcG silencing by polymerization of the SAM domain of the
Polyhomeotic subunit of canonical PRC1 complexes (Isono
et al., 2013) may represent one such mechanism.
Our results support a view that PcG localization in vertebrate
cells is dictated in large part by the distribution of unmethylated
CpG sites. Thismechanismmay also operate in other organisms,
such as inA. thaliana, where hypomethylation of DNA at transpo-
sons in amet1 mutant or endogenously in the endosperm results
in PRC2 recruitment (Deleris et al., 2012; Weinhofer et al., 2010).
However, this cannot account for PcG distribution patterns in
Drosophila and C. elegans, where there is no DNA methylation.
Nevertheless, there is an interesting parallel in C. elegans, where
mutation of the H3K36me2/3 methyltransferase MES4 results inFigure 5. DNA Methylation Does Not Inhibit PcG Activity Directly
(A) Schematic showing in vitro methylation of 601 positioning DNA and reconstit
(B) PRC2 histone methyltransferase assay using 3H SAM and either WT/H3Kc36m
bottom panels: Coomassie-stained gel; middle panel: autoradiography of dried g
(C) PRC1 ubiquitylation assay using WT/methylated DNA nucleosomes as subst
(D) Schematic of MBD tethering assay to target proteins of interest to regions of
(E) MBD-Ezh2-Flag transfected into E14 ESCs stained for Flag and H3K27me3
(n > 200).
(F) As in (E), but transfected with MBD-Ring1B-Flag and stained for Flag and H2
(G) As in (E), but transfected with MBD-Ezh2-Flag and stained for Flag and H2AK
(H) MBD-Ezh2-Flag transfected into MEFs and stained for Flag and H3K27me3.
Scale bars represent 5 mm. See also Figure S5.
CPRC2 relocalization from the X chromosome to autosomes
in germ cells (Gaydos et al., 2012). Thus, inhibition of PRC2 by
specific histone modifications could be used as an alternative
mechanism to limit sites of activity and hence define patterns
of occupancy of PcG complexes.
Monoubiquitylation of H2A Recruits PRC2
Our findings illustrate that unmethylated CpG is an important
determinant of PcG occupancy in mammalian cells. However,
although we cannot entirely rule out some contribution, we do
not find evidence that this is due to direct inhibition of PRC1/2
enzymatic activity by methylated CpG. Similarly, inhibition of
PRC2 by H3K36me2, as predicted on the basis of in vitro studies
(Schmitges et al., 2011), does not appear to be a primary deter-
minant of PcG localization in mammalian cells in vivo. Again, we
cannot entirely rule out the possibility that H3K36me2 may have
some role in limiting PRC2 activity at non-PcG target domains.
Our findings do, however, support an alternative model: the
sequential recruitment of variant PRC1 to unmethylated CpG,
notably via binding of the CXXC domain of the KDM2B protein,
and indirect recruitment of PRC2 in response to PRC1-mediated
H2AK119u1. Recruitment of PRC2 in response to H2AK119u1
deposition is substantiated by the observation that acquisi-
tion of H3K27me3 at PCH shows a linear relationship with
H2AK119u1, as seen in a comparison of KDM2B, Ring1B, and
RPCD tethering (Figures 6 and 7). Furthermore, only catalytically
active RPCD brings in H3K27me3, and in coIP experiments
we did not find a direct interaction between RPCD and either
PRC1 or, importantly, PRC2 subunits. This is also supported
by a mass spectrometry analysis of TetR-RPCD (Blackledge
et al., 2014). We found no evidence that RPCD-mediated
H2AK119u1 results in DNA hypomethylation, which could poten-
tially account for recruitment of endogenous PRC1/2 to PCH.
Consistent with this, recruitment of RPCD to a TetR array that
does not have any CpG sites also leads to establishment of
H3K27me3 (N.P.B., A.M. Farcas, T. Kondo, H.W. King, J.F.
McGouran, L.L.P. Hanssen, S. Ito, S.C., K. Kondo, Y. Koseki,
T. Ishikura, H.K. Long, T.W. Sheahan, N.B., B.M. Kessler, H.K.,
and R.K., unpublished data).
The finding that H2AK119 ubiquitylation is sufficient to recruit
PRC2 to chromatin was largely unanticipated, although, interest-
ingly, a prior study noted a loss of H3K27me3 in Ring1A/B DKO
ESCs (Endoh et al., 2008). This has been substantiated in
a recent study (N.P.B., A.M. Farcas, T. Kondo, H.W. King, J.F.
McGouran, L.L.P. Hanssen, S. Ito, S.C., K. Kondo, Y. Koseki,
T. Ishikura, H.K. Long, T.W. Sheahan, N.B., B.M. Kessler, H.K.,ution of dinucleosomes.
e3 nucleosomes or WT/methylated DNA nucleosomes as substrate. Top and
el.
rate, and analyzed by western blot (probed for H2AK119u1 or H3).
methylated DNA.
. The percentage of cells that showed the illustrated phenotype is indicated
AK119u1.
119u1.
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Figure 6. KDM2B and Ring1B Recruit PRC2 Activity to PCH Domains
(A) Schematic of MBD-KDM2B-Flag indicating the positions of mutations in the JmjC domain (HID-AAA) and the CxxC domain (K-A).
(B) MBD-KDM2B transfected into E14 ESCs stained for Flag and H2AK119u1 (left) and Flag and H3K27me3 (right).
(C) MBD-KDM2B-Flag catalytic mutant (JmjCmutant HID-AAA) transfected into E14 ESCs stained for Flag and H2AK119u1 (left), and Flag and H3K27me3 (right).
(D) Inducible stable line expressing MBD-Ring1B-Flag, stained for Flag and H2AK119u1 3 days after induction with doxycycline (left) and Flag and H3K27me3
(right).
(E) Graph showing the percentage of transfected cells with H2AK119u1 (gray) or H3K27me3 (black) PCH foci in cells transfected with WT MBD-KDM2B and
catalytically inactive JmjC domain mutant. Bars show average (n > 200 transfected cells) ± SD (n > 3).
(F) Graph showing the percentage of cells with H2AK119u1 (gray) or H3K27me3 (black) PCH foci in stable MBD-KDM2B and stable MBD-Ring1B either with or
without 3 days induction with doxycycline (n > 100 cells) ± SD (n > 3). Arrowheads indicate an example of staining within Flag domains at PCH.
Scale bars represent 5 mm. See also Figures S5 and S6.and R.K., unpublished data). Taken together, these observations
demonstrate hierarchical recruitment of PRC2 by PRC1 activity.
The data are consistent with a primary role for variant PRC1 and
H2AK119u1 in determining PcG target sites, although we do not
rule out the possibility that PRC2may also be recruited indepen-
dently of H2AK119u1.1466 Cell Reports 7, 1456–1470, June 12, 2014 ª2014 The AuthorsA key question for future studies is: what is the mechanistic
basis for H2AK119u1-mediated recruitment of PRC2? One
possibility is that PRC2 acts as a reader of H2AK119u1, either
directly or via a cofactor that can bind the modified chromatin
(see Figure 7D, top panel). Consistent with this idea, a previous
study identified the ZRF1 protein as an H2AK119u1-binding
Figure 7. Ubiquitylated H2A Is Sufficient to Recruit PRC2 to PCH Domains
(A) Structure of the minimal E3 and E2 complex (Bentley et al., 2011), showing the catalytic domain of Pcgf4 (yellow) and Ring1B (orange) interacting with E2
enzyme (blue). RPCD was made by fusing the C terminus (S116) of Ring1B to the N terminus (R3) of Pcgf4 using a 4x GGS flexible linker. Catalytic mutant (mut)
RPCD comprised C51G (in Pcgf4) and I53A (in Ring1B).
(B) Inducible stable line expressing MBD-RPCD-Flag or MBD-mut-RPCD-Flag, stained for Flag and H2AK119u1 3 days after induction with doxycycline (left) and
Flag and H3K27me3 (right). Arrowheads indicate an example of staining within Flag domains at PCH.
(C) Graph showing the percentage of cells with H2AK119u1 (gray) or H3K27me3 (black) PCH foci in stable MBD-Ring1B-Flag, MBD-RPCD-Flag, and MBD-mut-
RPCD-Flag cell lines, either with or without 3 days induction with doxycycline (n > 100 cells) ± SD (n > 3).
(D) Schematic to illustrate potential models of for PRC2 recruitment by H2AK119u1, either by direct/indirect protein interactions ‘‘reader’’ (top) or by ‘‘chromatin
state’’ (bottom).
Scale bars represent 5 mm. See also Figure S7.protein (Richly et al., 2010). Alternatively, H2AK119 ubiquitylation
may affect chromatin structure in such a way as to facilitate the
binding and/or activity of PRC2 complexes (Figure 7D, bottomCpanel). In this context, it should be noted that H2AK119u1
does not stimulate PRC2 activity on mononucleosome sub-
strates in vitro (Whitcomb et al., 2012). Conversely, a recentell Reports 7, 1456–1470, June 12, 2014 ª2014 The Authors 1467
study revealed that chromatin compaction stimulates PRC2
(Yuan et al., 2012), consistent with the idea that local chromatin
configuration is important.
In summary, our findings provide insights into the link between
DNA methylation and PcG recruitment, and are consistent with
the recently suggested model in which Polycomb recruitment
in vertebrates is a default state at licensed chromatin sites,




E14TG2A, Dnmt TKO (Dnmt1/, Dnmt3a/, Dnmt3b/) and matched
WT (J1) (Tsumura et al., 2006), conditional Uhrf1 and Dnmt1 knockout cells
(Sharif et al., 2007), constitutive Suv3-9h1/h2 DKO and matched WT ESCs
(Peters et al., 2003), and Dnmt1/ MEFs and matched control MEFs
(Lande-Diner et al., 2007) were cultivated using established methods. See
also Supplemental Experimental Procedures.
Constructs
Amino acids 1–112 of human MBD1, which include the MBD domain
and endogenous nuclear localization sequence (NLS) signal, followed by a
glycine- and serine-rich flexible linker, were cloned to the N terminus of the
protein of interest in pBluescript. An SV40 NLS, followed by a FLAG-tag,
was cloned on the C terminus of the protein of interest. These MBD-fusion
proteins were then cloned into the mammalian expression plasmid pCAG,
in which the MBD-fusion protein was under the control of the constitutive
b-actin promoter. Full-length mouse Ezh2, mouse Ring1B, and human
KDM2A (K601A) and KDM2B (K643A) were targeted to methylated DNA using
the MBD domain. For KDM2A/B, the CxxC DNA binding domains were
mutated (K601A and K643A, respectively). The MBD-KDM2B, MBD-Ring1B,
MBD-RPCD, and MBD-mutRPCD constructs were also cloned into the pTight
vector to allow doxycyline-inducible expression when stably integrated into
rtTA2A10 ESCs.
Amino acids 1–116 of Ring1B and 3–109 of Pcgf4 (termed Ring1b Pcgf4
catalytic domain RPCD fusion) were joined using a 4x GGS flexible linker
and cloned with an N-terminal GST tag in pGex-6p2 for bacterial protein
expression and purification, or with an N-terminal MBD domain in the pCAG
vector, for expression in ESCs. Catalytic mutants were made in the JmjC
domain of KDM2B (H242A, I243A, D244A) and in RPCD at Ring1B I53A
to mutate the E2 interaction domain, and at Pcgf4 C51G to mutate the zinc
finger domain, using a site-directed mutagenesis kit (Stratagene). Synthesized
core PRC2 subunits (full-length EZH2, EED, SUZ12, and RbAp48) were codon
optimized for expression in insect cells (GeneArt) and cloned into pBAC4x-1
(Novagen) using the In-Fusion cloning system (Clontech).
Immunofluorescence
ESCs or MEFs were split onto slides 16 hr before staining at low density
(without feeders). Slides were then washed in PBS, fixed with 2% formalde-
hyde in PBS for 15 min, and permeabilized with 0.4% Triton X-100 in PBS
for 5 min. After washing with PBS, the slides were blocked for 30 min in
0.2% fish gelatin (Sigma) in PBS and incubated for 2 hr with primary antibody
(diluted in 0.2% fish gelatin and 5% normal goat serum). Slides were washed
three times in 0.2% fish gelatin and incubated for 2 hr with Alexa Fluor conju-
gated secondary antibody (Life Technologies). After two washes in fish gelatin
and two washes in PBS, the slides were stained with DAPI (1 mg/ml) and
mounted using mounting media (Dako).
The following primary antibodies were used for IF: H2AK119u1 (1:500, rabbit
monoclonal, 8240; Cell Signaling Technology), H3K27me3 (1:500, rabbit poly-
clonal, pAB-069-050; Diagenode), H3K27me3 (1:1,000, mouse monoclonal,
61017; Active Motif), Flag (1:500, mouse M2 monoclonal; Sigma), H3K9me3
(1:500, rabbit polyclonal 39161; Active Motif), H3K4me3 (1:500, rabbit poly-
clonal, ab8580; Abcam), HP1a (1:500, mouse monoclonal MAB3584; Milli-
pore), and GFP (1:100, mouse monoclonal, sc-9996; Santa Cruz).1468 Cell Reports 7, 1456–1470, June 12, 2014 ª2014 The AuthorsChromatin Immunoprecipitation
ChIP/ChIP-seq was carried out as described previously (Blackledge et al.,
2010). Full details are provided in the Supplemental Experimental Procedures.
The antibodies for ChIP-seq were H3K27me3 (pAB-069-100; Diagenode),
H3K36me3 (AB9050; Abcam), anti-Suz12 (3737S; Cell Signaling Technology),
and anti-Ring1B (Atsuta et al., 2001).
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